Search results
81 Results for 'Pamela Silver'
- Technologies (6)
- Collaborations (0)
- Team (0)
- News (58)
- Pages (0)
- Multimedia (12)
- Publications (0)
- Jobs (0)
- Events (5)
Technologies 6
-
PFASense: Fast, In-Field Testing for Forever Chemicals
PFASense is a next-generation diagnostic tool designed to detect toxic ‘forever chemicals’ directly at the source. By combining engineered protein sensors with a portable electrochemical device, it enables real-time, low-cost monitoring of water supplies—providing actionable insights to protect health and guide remediation. -
Lactation Biologics: Increasing Milk Production for Healthier Babies
Lactation Biologics is developing a long-lasting, self-injectable treatment to help nursing mothers feed their babies naturally, helping them get the best nutrition possible in the face of climate disasters and supply chain disruptions. -
Pancreatitis Tx: An Engineered Protein Treatment for Pancreatitis
First disease-modifying therapy that can be systemically applied to safely and effectively treat patients with different forms of pancreatitis. -
Circe: Transforming greenhouse gases into valuable products with microbes
Circe Bioscience is using gas fermentation to produce valuable materials including fats, oils, and fuels from greenhouse gases using engineered microbes. -
Targeted EPO: Safely Normalizing Oxygen Delivery in a Broad Range of Disease Conditions
General Biologics commercializes Targeted EPO as a first-in-class fusion protein therapeutic for the treatment of life-threatening and limiting hypoxia in various disease conditions, including COPD, cystic fibrosis, COVID-19, and severe anemias, such as in patients with kidney failure. -
Bioplastics
Humans have produced roughly 8,300 million metric tons of plastic since the 1950s, the vast majority of which has been thrown out as waste. Only about 9% of that plastic waste has been recycled and 12% has been incinerated, leaving 79% of it to accumulate on our land and oceans, harming the environment, the food...
News 58
Multimedia 12
-
Video/Animation20-ish Questions with Pamela Silver20-ish Questions shows a different side of Wyss Institute faculty, touching on aspects of their personal life, hobbies, interests, as well as their research. This round follows Pamela Silver, a Founding Core Faculty member of the Wyss Institute as well as the Elliot T. and Onie H. Adams Professor of Biochemistry and Systems Biology at... -
Video/AnimationEnhancing Lactation to Improve Infant and Maternal HealthLactation Biologics is developing a long-lasting, self-injectable treatment to help nursing mothers feed their babies naturally, helping them get the best nutrition possible in the face of climate disasters and supply chain disruptions. Credit: Wyss Institute at Harvard University -
Video/AnimationThe Game-Changing Potential of mRNA VaccinesPromising mRNA vaccines years ago emerged from early-stage development, only to stall before proving themselves in clinical trials. Pushed by pandemic urgency across the notorious “Valley of Death,” this platform vastly exceeded expectations and is now poised to transform the vaccine R&D landscape. During the early months of the historic rollout of COVID-19 vaccines, Sabin’s... -
Video/AnimationCirce: Using Microbes to Make Biodegradable ProductsCurrent manufacturing methods release harmful greenhouse gases and pollution, and many of the products produced do not biodegrade, damaging our ecosystems even further. What if we could turn greenhouse gases into biodegradable products? Researchers at the Wyss Institute are using synthetic biology to make this a reality. Credit: Wyss Institute at Harvard University -
Video/AnimationEngineered Cross-feeding in Bacterial ConsortiaThrough engineered amino acid cross-feeding, researchers at the Wyss Institute and Harvard Medical School modified multiple bacterial strains to reverse antagonistic interactions and develop symbiotic relationships, resulting in a more balanced consortium and paving the way for future bacteria-based therapeutics. Credit: Wyss Institute at Harvard University -
Video/AnimationDistributed Cell Division CounterGenetically engineered E. coli containing a fluorescing red protein enabled a Wyss Institute and Harvard Medical School team to analyze the population fluctuations of gut microbes by comparing proportion of “marked” to “unmarked” cells. Credit: Wyss Institute at Harvard University
Events 5
-
Sep 3, 2019
Symposium
- Add to Calendar
- iCalendar
- Google Calendar
- Outlook
The GSAS Harvard Biotechnology Club 20th anniversary symposium will celebrate 20 years of student-driven connections between academia and industry. This meeting will highlight seminal achievements in biotech innovation and commercialization that have occurred since the inception of the club in 1999, especially those which have made a measurable impact on patients’ lives. A theme of... -
Jun 7, 2019, 8:00am - 6:00pmSymposium
- Add to Calendar
- iCalendar
- Google Calendar
- Outlook
Wyss Core Faculty member Pam Silver will be the keynote speaker at the Mid-Atlantic Synthetic Biology Symposium at the University of Virginia. Her talk is entitled, “Designing Biology for Health and Sustainability.” This event is a one-day meeting of the mid-Atlantic Synthetic Biology community. -
Nov 27, 2018, 1:00pm - 2:00pmLecture
- Add to Calendar
- iCalendar
- Google Calendar
- Outlook
On Tuesday, November 27, join Brigham and Women’s Hospital for the weekly Clinical Pathology Conference lecture series featuring Wyss Core Faculty member Pamela Silver. Pamela Silver is leveraging synthetic biology to build cells that act as sensors, memory devices, and drug delivery agents. Among her recent innovations are bacteria that sense and respond to gut... Free and open to public